Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases

Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases

Objective: To explore the clinical value of serum PGI, PGII, PGI/PGII, G-17 levels and Hp-IgG antibody in the preliminary screening of gastric diseases. Methods: A total of 300 patients who underwent gastroscopy in the Gastroenterology Department of our hospital from July 2018 to July 2020 due to ga...

Full description

Bibliographic Details
Main Author:	LI Nana, QI Tao, ZHU Liming
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2022-08-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|gastric cancer screening\|pepsinogen\|gastrin-17\|helicobacter pylori igg antibody
Online Access:	http://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1667814388860-1891059619.pdf

Similar Items

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
by: Jun-peng Zhou, et al.
Published: (2022-08-01)

Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy
by: Marcis Leja, et al.
Published: (2014-01-01)

Analysis of gastrin‐17 and its related influencing factors in physical examination results
by: Junchao Zeng, et al.
Published: (2023-10-01)

Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
by: Mosalreza Hosseini, et al.
Published: (2013-01-01)

Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
by: Claudia Robles, et al.
Published: (2022-07-01)

Helicobacter pylori infection and serum pepsinogen concentrations in an elderly population representative of Costa Rica
by: Clas Une, et al.
Published: (2022-01-01)

Combination of Serum Test and Questionnaire in Early Gastric Cancer Screening
by: Qiang Li, et al.
Published: (2022-08-01)

Correlation between Interleukin-17, High Sensitivity C-Reactive Protein and Pepsinogen in <i>Helicobacter pylori</i> Infected Gastritis
by: Jeanne Winarta, et al.
Published: (2024-01-01)

A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
by: Valli De Re, et al.
Published: (2023-02-01)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
by: Shogo Kikuchi, et al.
Published: (2019-04-01)

Serological Changes after Equivocal Helicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability
by: Ji Hye Kim, et al.
Published: (2017-10-01)

The central role of gastrin in gastric cancer
by: Helge Waldum, et al.
Published: (2023-10-01)

Detection of pepsinogen and Helicobacter pylori in preschool age children with secretory otitis media
by: Wael F Ismaeil, et al.
Published: (2018-01-01)

Gastric mucosa structure in patients with different serum pepsinogen levels and ratios
by: V. V. Tsukanov, et al.
Published: (2018-10-01)

Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway
by: Niluka Gunawardhana, et al.
Published: (2018-01-01)

DIAGNOSTIC ACCURACY OF GASTROPANEL® FOR ATROPHIC GASTRITIS IN BRAZILIAN SUBJECTS AND THE EFFECT OF PROTON PUMP INHIBITORS
by: Rejane MATTAR, et al.
Published: (2020-06-01)

Serum Assay Findings after Successful Helicobacter pylori Eradication
by: Sun-Young Lee
Published: (2021-12-01)

Serological assessment of gastric mucosal atrophy in gastric cancer
by: Bornschein Jan, et al.
Published: (2012-01-01)

Comparison of Serum Gastrin Level with Anti–Helicobacter Pylori Antibody in Helicobacter Pylori Infected Patients with and without Peptic Ulcer
by: Mohammadi S, Firouzjahi AR, Shokri Shirvani J, Bijani A
Published: (2011-09-01)

The ABC Method and Gastric Cancer: Evidence From Prospective Studies
by: Shizuka Sasazuki
Published: (2016-12-01)

Increased Prevalence of Autoimmune Gastritis in Patients with a Gastric Precancerous Lesion
by: Xiaopei Guo, et al.
Published: (2023-09-01)

Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study
by: Yalda Lucero, et al.
Published: (2021-02-01)

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study
by: Fumie Ikeda
Published: (2016-12-01)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
by: Tsung-Hsien Chiang, et al.
Published: (2022-02-01)

Evaluation of Serum Levels of Anti-Helicobacter pylori IgG and IgA by ELISA Method in Patients with Gastric Ulcer in Chalous, Iran
by: Arezoo Taravat, et al.
Published: (2024-01-01)

Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study
by: Yuling Tong, et al.
Published: (2021-08-01)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
by: Valli De Re, et al.
Published: (2021-01-01)

Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
by: Danute Razuka-Ebela, et al.
Published: (2022-05-01)

Potentialities of a serological method in diagnosis of atrophic gastritis
by: S I Pimanov, et al.
Published: (2008-02-01)

A Five-Year-Old Boy with Marked Hypergastrinemia Associated with H. pylori Infection
by: Asako Nakata, et al.
Published: (2010-09-01)

Comparison of salivary and serum IgG antibody in diagnosis of Helicobacter Pylori
by: M.Nasrolahei (Ph.D), et al.
Published: (2003-03-01)

Changes of serum pepsinogen level and ABC classification after bariatric surgery
by: Ming-Lun Han, et al.
Published: (2021-06-01)

Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
by: Reuben Veysey-Smith, et al.
Published: (2021-11-01)

Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers
by: Michele Russo, et al.
Published: (2023-01-01)

Diagnostic performance of the normal range of gastrin calculated using strict criteria based on a combination of serum markers and pathological evaluation for detecting gastritis: a retrospective study
by: Naoko Nagasaki, et al.
Published: (2023-05-01)

Salivary IgG assay to detect Helicobacter pylori infection in an Indian adult population
by: Ramya Thirumala Krishnaswamy, et al.
Published: (2012-01-01)

Gastrin and the Moderate Hypergastrinemias
by: Jens F. Rehfeld
Published: (2021-06-01)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
by: Khitam Muhsen, et al.
Published: (2019-07-01)

The Effect of Helicobacter Pylori Colonization on Enterochromaffin-Like (ECL) Cell and Gastrin (G) Positive Cells in Rat Stomach
by: Mohammad Ali Rezaee, et al.
Published: (2014-10-01)

Role of Helicobacter pylori eradication in the prevention of gastric cancer
by: V V Tsukanov, et al.
Published: (2014-08-01)